Evofem Biosciences, Inc. (EVFM) › Operating IncomeEvofem Biosciences, Inc. (EVFM) — Operating IncomeAnnual figures by period end, from SEC filings.2013-12-31: -$14.42M2014-12-31: -$9.59M2015-12-31: -$42.05M2016-12-31: -$12.04M2017-12-31: -$35.69M2018-12-31: -$77.64M2019-12-31: -$52.74M2020-12-31: -$103.62M2021-12-31: -$166.80M2022-12-31: -$84.12M2023-12-31: -$17.85M2024-12-31: -$7.68M2025-12-31: $3.37M$3.37M2013-12-31Operating Income (USD)2025-12-31Period endedOperating IncomeChange YoYSource filing2025-12-31$3.37M—2026-03-11From 2025-01-012024-12-31-$7.68M—2026-03-11From 2024-01-012023-12-31-$17.85M—2025-03-24From 2023-01-012022-12-31-$84.12M—2024-03-27From 2022-01-012021-12-31-$166.80M—2023-04-27From 2021-01-012020-12-31-$103.62M—2022-03-10From 2020-01-012019-12-31-$52.74M—2021-03-04From 2019-01-012018-12-31-$77.64M—2020-03-12From 2018-01-012017-12-31-$35.69M—2019-03-01From 2017-01-012016-12-31-$12.04M—2018-02-26From 2016-01-012015-12-31-$42.05M—2018-02-26From 2015-01-012014-12-31-$9.59M—2017-03-23From 2014-01-012013-12-31-$14.42M—2016-03-29From 2013-01-01Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)